|Year : 2007 | Volume
| Issue : 5 | Page : 240-244
Activity of aqueous ethanol extract of Euphorbia prostrata ait on Shigella dysenteriae type 1-induced diarrhea in rats
Kamgang Rene1, Gonsu Kamga Hortense2, Wafo Pascal3, Mbungni N Jean Alexis1, Pouokam Ervice Vidal1, Fokam Tagne Michel Archange1, Fonkoua Marie Christine4
1 GEMS, Animal Physiology Laboratory, Faculty of Sciences, University of Yaounde I, P.O. Box 8127, Cameroon
2 Faculty of Medicine and Biomedical Sciences, Bacteriology Laboratory UHC, University of Yaounde I, P.O. Box 8127, Cameroon
3 Chemistry Laboratory, Ecole Normale Supérieure, University of Yaounde I, P.O. Box 8127, Cameroon
4 Bacteriology Laboratory, Centre Pasteur of Cameroon, Yaounde, Cameroon
|Date of Submission||27-Jan-2007|
|Date of Decision||01-Jun-2007|
|Date of Acceptance||12-Oct-2007|
GEMS, Animal Physiology Laboratory, Faculty of Sciences, University of Yaounde I, P.O. Box 8127
Aim: Euphorbia prostrata (Euphorbiaceae) is traditionally used in Cameroon for the treatment of many diseases, including diarrhea. We investigated the acute toxicity and effect of the aqueous ethanol extract of the plant on gastrointestinal propulsion, in vitro bacterial growth and in vivo bacillary dysentery.
Materials and Methods: Diarrhea was induced by oral administration of 12 x 10 8 Shigella dysenteriae type 1 (Sd1) cells. Diarrheic rats were treated for 5 days with 10, 20 or 40 mg/kg extract or 20 mg/kg norfloxacin. The faeces frequencies and the number of Sd1 were assessed and the death rate recorded.
Results: The aqueous ethanol extract of E. prostrata was not toxic. In vitro, the minimal inhibitory and minimal bactericidal concentrations of the extract were 3,500 and 12,000 µg/ml, respectively. In vivo, diarrhea went along with increase in faeces frequency (P < 0.01 by the 3 rd day), increase in the bacterial population to a maximum on the 2 nd day after infection (P < 0.01). The death rate in diarrheic control group was 100% by day 6. E. prostrata extracts (20 and 40 mg/kg), like norfloxacin, reduced the bacterial growth (P < 0.01), so that by the 6 th day Sd1 density was <100 and no death was recorded. There was a significant (P < 0.01) reduction in faeces frequencies. The extract exhibited notable (P < 0.01) inhibition of intestinal propulsion.
Conclusion: The results suggest that E. prostrata possesses bactericidal and antidiarrheic properties and could be a therapeutic alternative for diarrheas of bacterial etiology.
Keywords: Antidiarrheic activity, Euphorbia prostrate, rat, Shigella dysenteriae type 1
|How to cite this article:|
Rene K, Hortense GK, Pascal W, Jean Alexis MN, Vidal PE, Michel Archange FT, Christine FM. Activity of aqueous ethanol extract of Euphorbia prostrata ait on Shigella dysenteriae type 1-induced diarrhea in rats. Indian J Pharmacol 2007;39:240-4
|How to cite this URL:|
Rene K, Hortense GK, Pascal W, Jean Alexis MN, Vidal PE, Michel Archange FT, Christine FM. Activity of aqueous ethanol extract of Euphorbia prostrata ait on Shigella dysenteriae type 1-induced diarrhea in rats. Indian J Pharmacol [serial online] 2007 [cited 2014 Dec 22];39:240-4. Available from: http://www.ijp-online.com/text.asp?2007/39/5/240/37275
Diarrhea is responsible for 3.1 million deaths monthly the world over, with more than 600,000 due to shigellosis.  Shigella dysenteriae type 1 ( Sd1 ) is an endemic human pathogen, causing acute bacillary dysentery in regions with high population densities. Resistance to quinolone antibiotics has been reported for this organism which rapidly develops resistance to the current therapy. ,, Foreign multidrug-resistant Sd1 strains might be introduced into new communities through travel. Dominant clones of ciprofloxacin-resistant Sd1 were observed in Southeast Asia and in Canada. ,, In sub-Saharan Africa, factors like refugee camps, rainy season and hot climate favour shigellosis due to Sd1 .  In Ngoela, East Cameroon, a 16.4% fatality rate of Sd1 - Escherichia More Details coli 0157- Entamoeba histolytica -induced diarrhea was recorded.  Many Sd1 strains in this African region are resistant to most of the antibiotics generally available in rural health centres.  Effective medicinal molecules (fluoroquinolones, aminoglycosides, etc) are exceptional and less accessible (due to high cost). The resistance profile leaves few reliable and economical therapeutic options for Sd1 . In Africa, some medicinal plants are currently used against bacillary dysentery. , In the central, eastern, southern and western rural parts of Cameroon, Euphorbia prostrata (Euphorbiaceae) is very often used for the treatment of dysentery. This plant contains flavonoid and phenolic compounds and was demonstrated to have anti-inflammatory and analgesic properties. , In the traditional use for diarrhea treatment, a handful of fresh plant is boiled in 500 ml water for 15-20 min. The decoction (supernatant) is drunk: a teaspoonful (≈5 ml) for infant and half a teacup (≈125 ml) for adults are recommended twice a day.
In the present work, we undertook a study to verify the claim of the medicinal value of E. prostrata , in a model of human bacillary dysentery induced in rats.
| » Materials and Methods|| |
Animals used for the experiment
Three-month old albino mice (weighing 20-30 gm) and Wistar rats (weighing 170-210 gm) of either sex, bred in our animal house in the ambient environmental conditions, were used for toxicity and antimicrobial drug assessment, respectively. Animal housing and experiments in vivo were done according to the guidelines of the European Union on Animal Care (CEE Council 86/609)
that was adopted by the Institutional Committee of the Ministry of Scientific Research and Innovation of Cameroon. These animals were allowed water and food ad libitum. Rats were kept singly in metabolic cages. Diarrhea was induced in rats according to the method described earlier, using Shigella dysenteriae type 1 ( Sd1 ) strain provided by the Centre Pasteur of Yaoundι, Cameroon. , For this purpose, after verifying that the rats were not Sd1 carriers, each rat in the 5 groups (of 5 animals each) was orally administered 12 × 10 8 (the 4 McFarland standard) saline-diluted Sd1 cells.
Plant material and extract
The whole plant of Euphorbia prostrata Ait was collected in Yaounde, Cameroon and identified by the National Herbarium of Cameroon at Yaounde, where a voucher specimen was deposited (Reference 65 596/HNC). The whole aerial part was washed thoroughly with water, shade dried and ground; 1.5 kg of the powder was macerated for 4 days in 80% ethanol (5 L). The filtrate was evaporated to dryness in a rotary evaporator at 37˚C to yield 85 gm of dark green E. prostrata extract, which was subsequently dissolved in 1% DMSO.
The acute toxicity of the extract was evaluated in 56 normal albino mice separated into 7 groups of 8 mice each (4 males and 4 females). Each group was fasted for 24 h, after which they were treated once orally with one of the increasing doses of the extract: 0, 5, 10, 15, 20, 25 or 30 gm/kg bw; the volume of each administered dose did not exceed 1 ml. The mice were then observed for at least 48 h and up to 7 days, for death, lethargy, jerkiness, sensitiveness to noise and touch, stools quality and frequency. The dose of the extract that would kill 50% of the animal population (LD 50 ) by the route given was estimated graphically or by using the following formula: 
LD 50 = X s - d(∑p - ½)
X s : 100% lethal dose; d: interval between 2 successive doses; p: death ratio per group.
Preliminary phytochemical screening test
Screening of the phytochemical properties of the aqueous ethanol extract of E. prostrata was done using the following chemicals and reagents: , Mayer and freshly prepared Dragendoff“s reagents (for alkaloids), Liebermann-Buchard test (for terpenoids and sterols), [FeCl 3 and K 3 Fe(CN) 6 ] (for phenols and tannins), Shinoda test [(magnesium turnings and K 3 Fe(CN) 6 ] (for flavonoids), Molish test (α-naphtol and H 2 SO 4 ) (for polysaccharides), frothing test (for saponins), FeCl 3 and HCl (for phlobotannins) and NH 4 OH (for anthraquinones).
In vitro antimicrobial activity : The antimicrobial activities of aqueous ethanol extracts of E. prostrata were tested using both serial dilution in broth and agar diffusion methods. Sd1 inocula were standardized by matching the turbidity of the culture to the 0.5 McFarland standard, as recommended by the National Committee of Clinical and Laboratory Standards (Indiana, U.S.A.).  Bacterial suspensions were further diluted to obtain the 5 × 10 5 CFU inoculum. In the agar diffusion method, 500 µl Sd1 inocula was seeded over Mueller-Hinton II (Boetec) agar. The well technique was used and each well was filled with 200 µl of each drug solution: standard antibiotic for control (norfloxacin 5 µg), increasing doses of E. prostrata extract (0.01-200 mg) and 1% DMSO as negative control. After 18 h incubation at 37˚C, the inhibition diameters (Ų; in mm) against Sd1 were determined using a caliper square. The minimal inhibitory concentration (MIC) was defined as the lowest concentration of antimicrobial extract that prevented visible growth. This was confirmed spectrophotometrically and by a count of viable cells on Hektoen (Becton Dickinson and Company) agar. , The minimal bactericidal concentration (MBC) was determined as the lowest concentration of extract allowing only 0.01% survival for Sd1 . Each test was repeated three times.
In vivo antidiarrheic activity
Antimicrobial activity : Diarrheic rats were randomly divided into 5 groups, each containing 5 animals. When diarrhea appeared, animals were administered the antidiarrheic drugs twice daily by the oral route (using an orogastric tube) for 5 consecutive days: the first group (diarrheic control) received vehicle (1% DMSO); the second group received the antibiotic norfloxacin (Noroxine, Laboratory Merck Sharp and Dohme-Chibret MSD, Paris) 20 mg/kg; and groups 3-5 received 10, 20 and 40 mg/kg E. prostrata extract, respectively, with the aim to be as close as possible to the doses of the extract used traditionally (estimated at 20 mg/kg bw of extract for 60 kg adult). To make sure that the food given to the animals was not implicated as the cause of diarrhea, a group of 5 normal rats was used as negative control, receiving neither bacterial inoculum nor drug but only food and water. Stools were collected using a white cloth fixed under the bars supporting the animals in the metabolic cage. The frequencies of faeces were evaluated for 6 consecutive days following Sd1 administration. Enumeration of Sd1 in faeces was performed before the induction of diarrhea and after the appearance of diarrhea at 2, 26, 50, 74, 98 and 122 h. For this purpose, 0.5 gm faeces was homogenized in 4.5 ml sterile saline; serial dilutions were made and 500 µl of each dilution was seeded over Hektoen agar. After 24 h incubation at 37˚C, the number of CFU was determined. , Animals were observed for 7 days from the day on which diarrhea was induced and the death rate was recorded.
Gastrointestinal propulsion : Rats in groups of 5 each were fasted for 48 h with free access to water. Each animal was administered per os 0.5 ml of a charcoal suspension (5% charcoal powder in 10% Arabic gum) in water. Each rat received orally, 30 min prior to the administration of the charcoal meal, one of the two doses of E. prostrata extract: 40 or 60 mg/kg bw. The control group received an equal volume of 1% DMSO. Half an hour after the meal, the rats were sacrificed and the percentage length of intestine traversed by the charcoal solution from the pylorus to the caecum was determined. 
The results are expressed as means ± S.E.M (standard error of the mean). Bacterial densities were log 10 transformed before analysis of the means. Data were statistically evaluated using the analysis of variance (anova) with post hoc Dunnet's t-test. Differences between groups were considered significant at P < 0.05.
| » Results|| |
Single doses of E. prostrata extract elicited overt signs of toxicity from 15 gm/kg bw, progressively reducing different behavioural parameters-movement, sensitiveness to touch and noise and aversive behaviour-over a period of 48 h. After this time, animal behaviour returned to normal. No significant change was observed in the quality and frequency of the faeces. The first animal death was observed with an extract dose of 10 gm/kg bw and the LD 100 was found to be 25 gm/kg bw. Graphical and estimated LD 50 were 16.25 gm/kg bw.
In the water ethanol extract of E. prostrata , anthraquinones, flavonoids, phenols, phlobotannins, polysaccharides, saponins, tannins and terpenoids were identified. Alkaloids were not present in very high amounts.
Susceptibility to Sd1
In the agar diffusion method, the E. prostrata extracts were active against Sd1 . The inhibition diameter (Ų) began at 10 mg extract (Ų = 8.5 mm) and increased progressively up to Ų = 22.5 mm for 120 mg of the extract; the inhibition diameter (Ų) with norfloxacin was 22.5 mm. The susceptibility of Sd1 to E. prostrata was determined, with the MIC and MBC values being 3500 and 12,000 µg/ml, respectively.
Animal behaviour, stool quality and mortality : Normal rats receiving only the food did not exhibit any diarrheic sign. Four hours after inoculum administration the animals became calm, less mobile and curled up. The first diarrheic faeces was emitted within 24 h (the 2 nd day) and thereafter the rats recovered their mobility progressively and presented greater aggressiveness, which decreased over the following days, except in the case of the diarrheic control and 10 mg/kg E. prostrata treated groups. Diarrheic stools were either soft or liquid, containing mucus or moulded and smooth and very often mucus-linked. At times, the faeces appeared molded and lumpy or presented blood marks. Stools of diarrheic rats emitted a fetid odour that attracted midges. By the 4 th day of treatment, the stench vanished and by day 5, the midges stopped appearing. During the five days of therapy, no death was recorded with norfloxacin and E. prostrata extracts of 20 and 40 mg/kg, whereas 40 and 100% deaths were registered on day 6, respectively, in the 10 mg/kg E. prostrata and diarrheic control groups [Table - 1].
Stool bacterial density and frequency : In the stools of diarrheic control rats, Sd1 density increased significantly ( P < 0.01) from day 1 after diarrhea appeared: 3.9 x 10 9 and 2.6 x 10 9 by the 2 nd and 3 rd days, respectively, vs 1.2 x 10 9 administered. Compared with the diarrheic control and the initial value, the well-known antibiotic (norfloxacin) significantly ( P < 0.01) reduced Sd1 growth from the 1 st up to 6 th day after start of therapy; it showed bactericidal effects. Similar to norfloxacin, E. prostrata inhibited bacterial growth in a dose-dependant manner [Figure - 1]. E. prostrata extract at 10 mg/kg inhibited bacterial growth by the 3 rd day and beyond, maintaining the Sd1 density at a level similar to that administered. The extract, at the doses of 20 and 40 mg/kg, effectively ( P < 0.01) reduced Sd1 density from 26 h of therapy and beyond. Similar to norfloxacin (20 mg/kg), the extract (40 mg/kg) reduced the bacterial density by 82%. From the 2 nd day of treatment, the total faeces frequency, while increasing in control diarrheic rats, decreased in all the treated rats and significantly so from the 3 rd day [Figure - 2]A. The extract at the doses of 20 and 40 mg/kg, as well as the well-known drug norfloxacin, markedly reduced the diarrheic stool rate and frequency so that by the 5 th day diarrheic faeces frequencies were less than 10% of total stool, both in norfloxacin and 40 mg/kg extract treated rats [Figure - 2]B.
Gastrointestinal relaxant activity in vivo: Aqueous alcohol extract of E. prostrata significantly reduced the gastrointestinal propulsion of the charcoal solution meal. At oral doses 40 and 60 mg/kg there was 10% ( P < 0.05) and 17% ( P < 0.01) inhibition, respectively [Table - 2].
| » Discussion|| |
The purpose of the present work was to establish the scientific rationale for the traditional use of E. prostrata extracts in treating infectious diarrhea. Antidiarrheic effects of an 80% ethanol extract were investigated using in vitro bacterial inhibition and in vivo activity against Shigella dysenteriae A 1 - induced diarrhea in rats. Acute toxicity (LD 50 and overt signs) and phytochemical properties were also studied.
The assayed doses represented 6 x 10 -4 , 12 x 10 -4 and 25 x 10 -4 of the oral LD 50 . Since aqueous ethanol extract of E. prostrata at doses below 10 gm/kg did not provoke any change in the behaviour of normal animals and because the LD 50 value was much higher than 5 gm/kg, the extract can be considered safe for all practical purposes in the laboratory and for all medicinal uses, according to the WHO criteria. 
The in vitro study showed the extract's inhibitory activity against Sd1 , which was equiactive to norfloxacin. The extract's MIC and MBC values are seemingly high. These high values are almost certainly due to the fact that we used crude extract, since other studies have shown high MIC and MBC for the crude extracts of some shigellocidal plants.  A ratio of MBC/MIC < 4 could indicate a bacterial activity for E. prostrata .  This was further confirmed by the Sd1 count in stools, where the decrease of bacterial population was similar to that obtained with norfloxacin treatment. By the 5 th day, the bactericidal actions of both E . prostrata extract and the reference antibiotic norfloxacin were quite evident, with Sd1 density in the stool becoming less than a hundred.
Many diarrheic rats developed signs such as curling up, soft stools, glairy/bloody or mucus-linked lumpy faeces, and faeces with a fetid odour that likely expressed the presence of pus. These signs are typical of infectious or 'invasive' diarrhea.  Intestinal fermentation in diarrheic rats, by reducing the pH and increasing faecal bulk,  raised the faeces frequency. Sd1 swarming is responsible for shiga toxin production, which induces the production of an important reactive oxygen metabolite, the mediator nitric oxide (NO), which is implicated in the inflammation associated with diarrhea.  Toxin resulting from the bacterial swarming was suspected of being responsible for the limb weakness that occurred within 48 h in animals that did not pass stool  and also for animal deaths. Norfloxacin (noroxin, 20 mg/kg) and E. prostrata extract (20 and 40 mg/kg) reduced the bacterial population and at the same time may have slowed down the intestinal propulsion. Decrease in intestinal transit time could have led to exacerbation of enteroinvasive infections, but this might have been prevented by the bactericidal property of the extract and thereby resulted in the decrease in stool frequency.
Phytochemical assessment revealed the presence of phenols, saponins, flavonoids and tannins (and alkaloids) which possess antioxidant and anti-inflammatory activities. Flavonoids are responsible for the inhibition of intestinal motility and secretion, which could lead to a decrease in the frequency of wet faeces.  Infections may be prevented by the antimicrobial properties of some compounds, such as anthraquinones, saponins and phenols. In the course of its intestinal anti-inflammatory action, some flavonoids inhibit inducible NO synthase. This action, since NO is responsible for the behavioural changes, could lead to the reduction in aggressiveness as well as the reduction of mucus-coated stool and bloody diarrhea. , In addition to its use in diarrhea, E.prostrata is also traditionally used for the control of diabetes; the presence of tannins, polysaccharides, terpenoids, saponins, flavonoids (and alkaloids) in the extract probably explain its effect in this disease. E. prostrata extract progressively reduced the Sd1 density in the faeces. By the 4 th day of treatment, 40 mg/kg bw extract had reduced the Sd1 population by 48.5% and by 83.5% by the 6 th day. This progressive effect is of great importance because the toxin release that occurs with rapid destruction of microorganisms in vivo could lead to endotoxinic shock, which could result in high faeces frequency.  On the other hand, the rapid decrease in diarrheic stool (from the 4 th day onwards) is responsible for the disappearance of midges. This is also of great significance, since flies are implicated in the transmission of shigellosis.  The E. prostrata extract also abolished all the disorders observed in the Sd1 -induced diarrhea. It is therefore possible that the aqueous alcohol extract of E. prostrata is effective against infectious diarrhea through antibacterial and/or antitoxin actions. These actions need to be elucidated with further investigations. Furthermore, the extract's antidiarrheic effect could also result from the combined slowing down of stool ejection.
In this study, the S. dysenteriae type 1 strain was not resistant to the fluoroquinolone norfloxacin; the E. prostrata extract was found to be bactericidal; it inhibited behavioural changes, decreased stool frequency and prevented death in diarrheic animals. The bactericidal effect was comparable to that of the fluoroquinolone norfloxacin and was less sudden. All these antidiarrheic properties attest to the usefulness of E. prostrata in the treatment of diarrhea, especially infectious diarrheas such as Sd1- induced diarrhea.
| » Acknowledgments|| |
We acknowledge the Centre Pasteur of Yaoundι - Cameroon, for providing us Shigella dysenteriae 1 strain and the University of Yaoundι I for the university research support fund (URSF2000-2002).
| » References|| |
|1.||Sur D, Ramamurthy T, Deen J, Bhattacharya SK. Shigellosis : c0 hallenges and management issues. Indian J Med Res 2004;120 :40 54-62. |
|2.||Dutta S, Dutta D, Dutta P, Matsushita S, Bhattacharya SK, Yoshida SI. Shigella dysenteriae serotype 1, Kolkatta, India. Emerg Infect Dis 2003;9:1471-4. |
|3.||Naheed A, Kalluri P, Talukder KA, Faruque AS, Khatun F, Nair GB, et al . Fluoroquinolone-resistant Shigella dysenteriae type 1 in north-eastern Bangladesh. Lancet Infect Dis 2004;4:607-8. |
|4.||Sivapalasingam S, Nelson JM, Joyce K, Hoekstra M, Angulo FJ, Mintz ED. High Prevalence of Antimicrobial Resistance among Shigella Isolates in the United States Tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Antimicrob Agents Chemother 2006;50:49-54. |
|5.||Dutta S, Ghosh A, Ghosh K, Dutta D, Bhattacharya SK, Nair GB, et al . Newly emerged multiple antibiotic-resistant Shigella dysenteriae type 1 strains in and around Kolkatta, India, are clonal. J Clin Microbiol 2003;41:5833-4. |
|6.||Dutta S, Kawamura Y, Ezaki T, Nair GB, Iida KI, Yoshida SI. Alteration in the GyrA submit of DNA gyrase and the ParC submit of topoisomerase IV in Quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkatta, India. Antimicrob Agents Chemother 2005;49:1660-1. |
|7.||Pazhani GP, Sarkar B, Ramamurthy T, Bhattacharya SK, Takeda Y, Niyogi SK. Clonal multidrug-resistant Shigella dysenteriae type 1 strains associated with epidemic and sporadic dysenteries in eastern India. Antimicrob Agents Chemother 2004;48:681-4. |
|8.||Ndihokubwayo JB, Baribwira C, Ndayiragije A, Poste B. Antibiotic sensitivity of 299 strains of shigella isolated in Burundi. Med Trop (Mars) 1996;56:37-40. |
|9.||Cunin P, Tedjouka E, Germani Y, Ncharre C, Bercion R, Morvan J, et al . An epidemic of bloody diarrhea: Escherichia coli O157 emerging in Cameroon? Emerg Infect Dis 1999;5:285-90. |
|10.||Tarnagda Z, Diagbouga S, Sankara P, Kienou K, Yaro S, Van De Pierre P. Sensitivity to antibiotics strains of Shigella dysenteriae type 1 implicated in an outbreak in Burkina Faso. Medicine d“Afrique Noire 2001;48:141-4. |
|11.||Mshana NR, Abbiw DK, Addae-Mensah I, Adjanohoun JE, Ahyimira, Ekpere JA, Enow-Orock EG, et al . Traditional Medecine and pharmacopoeia contribution to the revision of ethnobotanical and floristic studies in Ghana Organisation of African. Unity/Scientific, Technical and Research Commission 2000. p. 243. |
|12.||Tona L, Kambu K, Mesia K, Cimanga K, Apers S, De Bruyne T, et al . Biological screening of traditional preparations from some medicinal plants used as antidiarrheal in Kinshasa, Congo. Phytomedicine 1999;6:59-66. |
|13.||Singla AK, Pathak K. Anti-inflammatory studies on Euphorbia prostrata . J Ethnopharmacol 1989;27:55-61. |
|14.||Singla AK, Pathak K. Topical antiinflammatory effects of Euphorbia prostrata on carrageenan-induced footpad oedema in mice. J Ethnopharmacol 1990;29:291-4. |
|15.||Kamgang R, Pouokam KE, Fonkoua MC, Penlap NB, Biwolι SM. Shigella dysenteriae type 1-induced diarrhea in Rats. Jpn J Infect Dis 2005;58:335-7. |
|16.||Kamgang R, Pouoka Kamgne EV, Fonkoua MC, Penlap N Beng V, Biwole Sida M. Activities of aqueous extracts of Mallotus oppositifolium on Shigella dysenteriae A 1 -induced diarrhea in Rats. Clin Exp Pharmacol Physiol 2006;33:89-94. |
|17.||Molle J. Limites de tolιrence et toxicitιs de quelques amino-acides (formes L et D). Amino-peptides-protιine, Cahier 24; Ed. A.E.C. 1986. p. 207-32. |
|18.||Odebiyi OO, Sofowora EA. Phytochemical screening of Nigerian medicinal plants. Lloydia 1978;41:234-46. |
|19.||Orech FO, Akenga T, Ochora J, Friis H, Aagaard-Hansen J. Potential toxicity of some traditional leafy vegetables consumed in Nyang“oma Division, Western Kenya. Afr J Food Nutr Sc (AJFAND) 2005;5:1-13. |
|20.||National Committee of Clinical and Laboratory Standards. Performance standards for antimicrobial susceptibility testing: fifteenth informational supplement. CLSI/NCCLS Document M100-S15. Clinical and Laboratory Standards Institute: Wayne, Pa; 2005 |
|21.||Carbonnelle B, Denis F, Marmonier A, Pinon G, Vargues R. Bactιriologies m0ιdicales t0 echniques u0 suelles . Simep: Paris; 1987. |
|22.||Islam MS, Hossain MZ, Khan SI, Felsenstein A, Sack RB, Albert MJ. Detection of non-culturable Shigella dysenteriae 1 from artificially contaminated volunteers` fingers using fluorescent antibody and PCR techniques. J Diarrhoeal Dis Res 1997;15 :60 5-70. |
|23.||Fish JT, Pettibone GW. Influence of freshwater sediment on the survival of Escherichia coli and Salmonella sp. as measured by three methods of enumeration. Lett Appl Microbiol 1995;20:277-81. |
|24.||Patnaik GK, Banaudha KK, Khan KA, Shoeb A, Dhawan BN. Spasmotytic activity of angelicin from Heracleum thomsoni . Planta Med 1987;53:517-20. |
|25.||Diezi J. Principe de base et repercussion clinique. In: Schoderet M. Pharmacologie: des principes fondamentaux aux applications thιrapeutiques. Frison-Roche, editor. 2 nd ed. Slatkine, Genθve: Paris; 1992. p. 33-5. |
|26.||Iwalokun BA, Gbenle GO, Adewole TA, Akinsinde KA. Shigellocidal properties of three Nigerian medicinal plants : O0 cimum gratissimum , Terminalia avicennoides and Mormodica balsamina . J Health Popul Nutr 2001;19 :30 31-5. |
|27.||Carre D, Chapalain JC, Debonne JM, Klotz F. Diarrhιes infectieuses aigu'λs. Encycl. Med. Chir , Maladies infectieuses, 8-003-V-10, 2000. p. 16. |
|28.||Cooke C, Carr I, Abrams K, Mayberry J. Arrowroot as a treatment for diarrhea in irritable bowel syndrome patients : a0 pilot study. Arq Gastroenterol 2000;37 :20 0-4. |
|29.||Sugi K, Musch MW, Di A, Nelson DJ, Chang EB. Oxidants potentiate Ca 2+- and cAMP-stimulated Cl - secretion in intestinal epithelial T84 cells. Gastroenterology 2001;120 :80 9-98. |
|30.||Ludwig K, Karmali MA, Smith CR, Petric M. Cross-protection against challenge by intravenous Escherichia coli verocytotoxin 1 (VT1) in rabbits immunized with VT2 toxoid . C0 an J Microbiol 2002;48 :90 9-103. |
|31.||Di Carlo G, Autore G, Izzo AA, Maiolino P, Mascolo N, Viola P, et al . Inhibition of intestinal motility and secretion by flavonoids in mice and rats: Structure-activity relationships. J Pharm Pharmacol 1993;45:1054-9. |
|32.||Balter-Seri J, Yuhas Y, Weizman A, Notech-Mozes Y, Kaminsky E, Ashkenazi S. Role of nitric oxide in the enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae . Infect Immun 1999;67 :60 364-8. |
|33.||Camuesco D, Comalada M, Rodriguez-Cabezas ME, Nieto A, Lorente MD, Concha A, et al . The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br J Pharmacol 2004;143 :90 08-18. |
|34.||Kernbaum S. Elements of infectious pathology, 6 th ed. Simep: Paris; 1996. |
|35.||Gentilini M. Tropical medicine, 5 th ed. Flammarion Mιdecine-Sciences:Paris; 1993. |
[Figure - 1], [Figure - 2]
[Table - 1], [Table - 2]
|This article has been cited by|
||Low-cost and eco-friendly green synthesis of silver nanoparticles using Feronia elephantum (Rutaceae) against Culex quinquefasciatus, Anopheles stephensi, and Aedes aegypti (Diptera: Culicidae)
| ||Kaliyan Veerakumar,Marimuthu Govindarajan,Mohan Rajeswary,Udaiyan Muthukumaran |
| ||Parasitology Research. 2014; |
||The traditional medical uses and cytotoxic activities of sixty-one Egyptian plants: Discovery of an active cardiac glycoside from Urginea maritima
| ||Hesham R. El-Seedi,Robert Burman,Ahmed Mansour,Zaki Turki,Loutfy Boulos,Joachim Gullbo,Ulf Göransson |
| ||Journal of Ethnopharmacology. 2013; 145(3): 746 |
||Evaluation of different extracts and synthesised silver nanoparticles from leaves of Euphorbia prostrata against Haemaphysalis bispinosa and Hippobosca maculata
| ||A. Abduz Zahir,A. Abdul Rahuman |
| ||Veterinary Parasitology. 2012; 187(3-4): 511 |
||Effects of oral administration of Euphorbia prostrata extract on the reproductive system of male albino rats: a histometric and biochemical study
| ||Hameed N. Bataineh, Mukhallad A. M. Mohammad |
| ||Comparative Clinical Pathology. 2010; |
||Hypolipidaemic effects of Euphorbia prostrata in rabbits
| ||Shahwan, M.J., Al-Qirim, T.M., Daradka, H. |
| ||Journal of Biological Sciences. 2009; 9(1): 88-91 |